Scibase AB Financials
| SCIB Stock | SEK 0.42 0.03 7.69% |
Scibase |
Please note, the imprecision that can be found in Scibase AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Scibase AB. Check Scibase AB's Beneish M Score to see the likelihood of Scibase AB's management manipulating its earnings.
Scibase AB Stock Summary
Scibase AB competes with Acarix AS, Episurf Medical, Xbrane Biopharma, Scandinavian Enviro, and Cantargia. SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007045414 |
| Business Address | Landsvgen , Sundbyberg, |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.scibase.com |
| Phone | 46 8 41 06 20 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Scibase AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Scibase Stock, because this is throwing your money away. Analyzing the key information contained in Scibase AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Scibase AB Key Financial Ratios
Scibase AB's financial ratios allow both analysts and investors to convert raw data from Scibase AB's financial statements into concise, actionable information that can be used to evaluate the performance of Scibase AB over time and compare it to other companies across industries.Scibase Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Scibase AB's current stock value. Our valuation model uses many indicators to compare Scibase AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scibase AB competition to find correlations between indicators driving Scibase AB's intrinsic value. More Info.Scibase AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scibase AB's earnings, one of the primary drivers of an investment's value.Scibase AB Systematic Risk
Scibase AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Scibase AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Scibase AB correlated with the market. If Beta is less than 0 Scibase AB generally moves in the opposite direction as compared to the market. If Scibase AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Scibase AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Scibase AB is generally in the same direction as the market. If Beta > 1 Scibase AB moves generally in the same direction as, but more than the movement of the benchmark.
Scibase AB December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Scibase AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Scibase AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Scibase AB based on widely used predictive technical indicators. In general, we focus on analyzing Scibase Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Scibase AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.64 | |||
| Information Ratio | 0.0415 | |||
| Maximum Drawdown | 26.0 | |||
| Value At Risk | (7.84) | |||
| Potential Upside | 11.43 |
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.